UroGen Pharma Ltd.
Nasdaq · Healthcare · Pharmaceutical Preparations · Ra'Anana, Israel
URGN chart
What traders are saying about $URGN
Latest postsUroGen Pharma Ltd. news
- (URGN) as a Liquidity Pulse for Institutional Tactics
Stock Traders Daily ·
- Is FDA Filing Acceptance Altering The Investment Case For UroGen Pharma (URGN)?
Simply Wall Street ·
- Why UroGen Pharma (URGN) Is Getting Fresh Attention Now
Yahoo Finance ·
- UroGen Announces FDA Acceptance of the New Drug Application for UGN-103, an Investigational Treatment for Adults with Recurrent LG-IR-NMIBC
Yahoo Finance ·
- Here's Why You Should Add URGN Stock to Your Portfolio Now
Yahoo Finance ·
- UroGen Pharma (URGN) Stock Looks Fairly Valued On Its Sales Base
Yahoo Finance ·
- Is Establishment Labs’ (ESTA) Profitability Inflection the Ultimate Buying Opportunity?
Yahoo Finance ·
- Is UroGen’s (URGN) Commercial Engine Strong Enough To Fund Its Pipeline Ambitions?
Yahoo Finance ·
- Tyra Biosciences Stock Plunges 22% as Bladder Cancer Pill Fails to Impress
Yahoo Finance ·
- UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- UroGen Pharma to Present at Upcoming Investor Conferences
Yahoo Finance ·
- Wall Street Analysts Think Urogen Pharma (URGN) Could Surge 27.14%: Read This Before Placing a Bet
Yahoo Finance ·
UroGen Pharma Ltd. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $109.8M | $90.4M | $82.7M | $64.4M |
| Net income | -$153.5M | -$126.9M | -$102.2M | -$109.8M |
| Total assets (year end) | $200.5M | $285.7M | $178.3M | $135.6M |
| Cash and equivalents (year end) | $110.7M | $172.0M | $95.0M | $55.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About UroGen Pharma Ltd.
- Ticker
- URGN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Ra'Anana, Israel
- Incorporated in
- Israel
- Fiscal year end
- December 31
- SEC CIK
- 1668243
Frequently asked questions
What exchange is UroGen Pharma Ltd. listed on?
UroGen Pharma Ltd. trades on the Nasdaq under the ticker symbol URGN.
What industry is UroGen Pharma Ltd. in?
UroGen Pharma Ltd. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is UroGen Pharma Ltd. headquartered?
UroGen Pharma Ltd.'s business address on file with the SEC is in Ra'Anana, Israel.
When does UroGen Pharma Ltd.'s fiscal year end?
UroGen Pharma Ltd.'s fiscal year ends on December 31.
How much revenue did UroGen Pharma Ltd. report?
UroGen Pharma Ltd. reported $109.8M in revenue for calendar year 2025, according to its SEC filings.